五味石膏汤加减联合针刺蝶腭神经节及地氯雷他定治疗过敏性鼻炎的效果观察

Effect observation of modified Wuwei Shigao Decoctioncombined with acupuncture of sphenopalatine ganglion and desloratadine in the treatment of allergic rhinitis

  • 摘要:
      目的  探讨五味石膏汤加减、针刺蝶腭神经节联合地氯雷他定治疗过敏性鼻炎的效果。
      方法  选取40例过敏性鼻炎患者,随机分为观察组与对照组各20例,对照组采用针刺蝶腭神经节联合地氯雷他定治疗,观察组在对照组基础上联合五味石膏汤加减治疗,比较2组治疗效果。
      结果  观察组总有效率95.00%, 显著高于对照组75.00%(P < 0.05)。治疗前, 2组流清涕、发作性鼻痒、鼻甲肿大、鼻塞等中医证候积分对比无显著差异(P>0.05);治疗后, 2组各证候积分较治疗前均显著降低(P < 0.05), 且观察组治疗后各症状积分均显著低于对照组(P < 0.05)。2组患者治疗前血清免疫球蛋白E(IgE)、血清嗜酸粒细胞阳离子蛋白(ECP)、血清嗜酸粒细胞(EOS)等指标比较无显著差异(P>0.05);治疗后, 2组上述指标水平较治疗前均显著下降(P < 0.05), 且观察组治疗后各指标水平均显著低于对照组(P < 0.05)。观察组不良反应发生率15.00%, 对照组不良反应发生率20.00%, 2组不良反应发生率比较无显著差异(P>0.05)。
      结论  过敏性鼻炎患者在针刺蝶腭神经节联合地氯雷他定治疗的基础上,联合应用五味石膏汤安全、有效,能缓解患者临床症状。

     

    Abstract:
      Objective  To investigate the effect of modified Wuwei Shigao Decoction combined with acupuncture of sphenopalatine ganglion and desloratadine in the treatment of allergic rhinitis.
      Methods  Totally 40 patients with allergic rhinitis were randomly divided into observation group and control group, with 20 cases in each group. The control group was treated with acupuncture of sphenopalatine ganglion combined with desloratadine, while the observation group was treated with modified Wuwei Shigao Decoction on the basis of the control group. The therapeutic effect of the two groups was compared.
      Results  The total effective rate of the observation group was 95.00%, which was significantly higher than 75.00% of the control group (P < 0.05). Before treatment, there were no significant differences in the scores of TCM syndromes such as runny discharge, paroxysmal nasal itching, turbinate enlargement and nasal obstruction between the two groups (P>0.05). After treatment, the score of each syndrome in both groups was significantly lower than that before treatment (P < 0.05), and the scores of symptoms in the observation group were significantly lower than those in the control group (P < 0.05). There were no significant differences in serum immunoglobulin E (IgE), serum eosinophil cationic protein (ECP) and serum eosinophil (EOS) between the two groups before treatment (P>0.05). After treatment, the above indexes in both groups were significantly lower than those before treatment (P < 0.05), and the indexes in the observation group were significantly lower than those in the control group after treatment (P < 0.05). The incidence rates of adverse reactions were 15.00% in the observation group and 20.00% in the control group, and there was no significant difference in the incidence rate of adverse reactions between the two groups (P>0.05).
      Conclusion  Based on the treatment of sphenopalatine ganglion combined with desloratadine, Wuwei Shigao Decoction is safe and effective for allergic rhinitis patients, which can relieve the clinical symptoms of patients.

     

/

返回文章
返回